Liposomes formulated with fMLP-modified cholesterol for enhancing drug concentration at inflammatory sites

Macrophages and liposomes in inflammatory disease: Friends or foes?

(2011) B.J. Crielaard et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Liposome formulated with TAT-modified cholesterol for improving brain delivery and therapeutic efficacy on brain glioma in animals

(2011) Yao Qin et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Liposome formulated with TAT-modified cholesterol for enhancing the brain delivery

(2011) Yao Qin et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Stealth nanoparticles: High density but sheddable PEG is a key for tumor targeting

(2010) Shyh-Dar Li et al.   JOURNAL OF CONTROLLED RELEASE

In vitroandin vivoinvestigation of glucose-mediated brain-targeting liposomes

(2010) Yao Qin et al.   JOURNAL OF DRUG TARGETING

Proteomic differentiation pattern in the U937 cell line

(2010) Luigi Minafra et al.   LEUKEMIA RESEARCH

Assessing the future of diffuse optical imaging technologies for breast cancer management

(2008) Bruce J. Tromberg et al.   MEDICAL PHYSICS

The development of allergic inflammation

(2008) Stephen J. Galli et al.   NATURE

Optimizing Size and Copy Number For PEG-fMLF (N-Formyl-methionyl-leucyl-phenylalanine) Nanocarrier Uptake by Macrophages

(2007) Li Wan et al.   BIOCONJUGATE CHEMISTRY